Top Marijuana Shares regarding the NASDAQ

Even though most of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade within the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose stocks which are listed on the NASDAQ with other exchanges because of the increased liquidity and tighter spreads set alongside the over-the-counter areas. As an example, whilst the cannabis industry has exploded in current months and years, uplisting from an OTC market to a professional U.S. change became an advertising achievement for all marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of businesses are increasingly being noted on reputable U.S. exchanges as opposed to being exchanged regarding the OTC market showing the fast growth of the cannabis industry.

NASDAQ-listed Marijuana Stocks

The NASDAQ ended up being the initial exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis businesses in the NASDAQ mirror this, therefore the most of them run within the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is really a biotech business involved in the production of medical cannabis drugs. Research and development around Arena’s APD371 may be the focus that is primary of company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a check this is certainly blank that is in a merger contract with Kalyx developing Inc. Kalyx is a prominent owning a home rely upon the regulated cannabis industry in the us.

Key Takeaways

  • The cannabis industry, specially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis has been utilized in brand new medications to treat discomfort and chronic that is many inflammatory, and fibrotic diseases.
  • Companies may also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette syndrome, epileptic problems, Prader-Willi Syndrome (an inherited condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although all the company’s clinical-stage items target opioid receptors, Cara is conducting research that is preclinical cannabinoids to treat neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The group’s research, development, and production are based around cannabis medications that seek to deal with chronic, inflammatory, fibrotic, along with other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is just a cannabis that are canadian. The team owns and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro maker Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but additionally with a partner that is well-established when you look at the marketing of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage accessories and vaporization gear and items to retail customers in the U.S. and Canada. Also, it runs websites that are e-commerce additional product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is creating a portfolio of cannabinoid medications. These medications consist of Sativex for the treating spasticity pertaining to sclerosis that is multiple cancer discomfort and Epidiolex to treat youth epilepsy. Sativex is commercialized much more than the usual dozen nations outside of the united states of america and contains gotten regulatory approval in some other countries. Epidiolex received Food And Drug Administration approval as a therapy plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of severe, very very early beginning epilepsy without good current treatment options. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical company that is developing drugs centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based drugs for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant wellness services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate to be used on cannabis plants when you look at the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is really a maker of beverages produced from yerba mate, cbd oil for sale green tea extract, kombucha, and comparable items. In current months, modern age has expanded its beverage offerings to incorporate CBD infusions also, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in May of 2019, which makes it the most recent cannabis organizations to record regarding the popular change. The organization happens to be quickly expanding its manufacturing capacity that can manage to create just as much as 113,000 kilograms of item per year by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs when you look at the enforcement sector. The company’s business operations support medication assessment through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the release of a brand new Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical business focused in the growth of cannabinoid-based drugs. Therapix’s current pipeline includes services and products targeted to treat Tourette problem and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being initial marijuana-related business to have a preliminary general public offering (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis products.

Village Farms International (NASDAQ:VFF)

Village Farms Global is one of present cannabis stock to begin dealing from the NASDAQ. The company’s stocks became readily available for trade on 21, 2019 february. The business possesses decades-long history in greenhouse produce manufacturing and it has just recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the growth of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic pain, and delicate X syndrome.

Leave a Reply

Latest E.I Facebook Update

No recent Facebook posts to show

News & Events